SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $12,536,000 | -76.1% | 436,477 | +16.8% | 1.03% | -33.5% |
| Q3 2019 | $52,444,000 | +94.3% | 373,828 | +120.3% | 1.55% | +159.9% |
| Q1 2019 | $26,987,000 | -44.3% | 169,676 | -66.5% | 0.60% | -53.7% |
| Q4 2018 | $48,448,000 | +807.1% | 505,776 | +573.0% | 1.29% | +860.4% |
| Q1 2017 | $5,341,000 | -15.9% | 75,158 | -62.1% | 0.13% | -31.6% |
| Q1 2016 | $6,350,000 | +166.6% | 198,058 | +384.8% | 0.20% | +172.2% |
| Q4 2015 | $2,382,000 | – | 40,850 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |